UPDATE - UBS initiates coverage on SUPERVALU (SVU) with a Sell; Probably Getting Worse Before It Gets Better
Get Alerts SVU Hot Sheet
Price: $32.49 --0%
Rating Summary:
1 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Rating Summary:
1 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Join SI Premium – FREE
UPDATE - UBS initiates coverage on SUPERVALU (NYSE: SVU) with a Sell rating. PT $5.50.
UBS analyst said, "We estimate SVU has just -11% profit headroom to its fixed charge covenant. Should profits continue to decline at their current trend, we estimate SVU would breach covenants. We think SVU has the right turnaround strategy, but its covenant limits its execution. We believe it is under investing in capex in its retail division (0.8x vs D&A) and is unable to make full investments in price reductions without vendor support. Food retailer turnarounds are gradual. But, the debt covenant is potentially a factor that stops the clock before the turnaround is complete."
UBS feels that the long-term reward could be high for the company and investors, but SVU will have to take action to alleviate constraints by either cutting dividend, issue equity or sell assets...short term pain could very well equal long term gains.
To see more ratings on SVU, Click Here
UBS analyst said, "We estimate SVU has just -11% profit headroom to its fixed charge covenant. Should profits continue to decline at their current trend, we estimate SVU would breach covenants. We think SVU has the right turnaround strategy, but its covenant limits its execution. We believe it is under investing in capex in its retail division (0.8x vs D&A) and is unable to make full investments in price reductions without vendor support. Food retailer turnarounds are gradual. But, the debt covenant is potentially a factor that stops the clock before the turnaround is complete."
UBS feels that the long-term reward could be high for the company and investors, but SVU will have to take action to alleviate constraints by either cutting dividend, issue equity or sell assets...short term pain could very well equal long term gains.
To see more ratings on SVU, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades UDR, Inc. (UDR) to Buy
- A strong earnings season looks likely to help restore market confidence - UBS
- Bread Financial Holdings, Inc. (BFH) Provides Performance Update for March 2024
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBS, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!